first biologically derived human therapeutic drugs, RENGEN and MENGEN, both of which helped to offset the damaging effects from chemotherapy for cancer patients undergoing treatment. Those two MoGen products were among the first “blockbuster” drugs to emerge from the nascent biotechnology industry.